Roche: Genentech parent Roche pledges $50 billion U.S. investment over five years
Genentech caved to President Trump's anti-DEI push. Now Roche is trying to get ahead of Trump's pressure, including with tariffs, to invest in the United States.
Read full article »
Roche is a Switzerland-based biotechnology company that discovers, develops, and provides diagnostic and pharmaceutical products and services for the healthcare sector.
Read more